Your browser doesn't support javascript.
loading
The case for replacing live oral polio vaccine with inactivated vaccine in the Americas.
Alfaro-Murillo, Jorge A; Ávila-Agüero, Marí L; Fitzpatrick, Meagan C; Crystal, Caroline J; Falleiros-Arlant, Luiza-Helena; Galvani, Alison P.
Affiliation
  • Alfaro-Murillo JA; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
  • Ávila-Agüero ML; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA; Paediatric Infectious Diseases Department, Hospital Nacional de Niños "Dr Carlos Sáenz Herrera", San José, Costa Rica. Electronic address: mlavila@ccss.sa.cr.
  • Fitzpatrick MC; Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Crystal CJ; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
  • Falleiros-Arlant LH; Paediatric Infectious Diseases Department, Universidade Metropolitana de Santos, São Paulo, Brazil.
  • Galvani AP; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA. Electronic address: alison.galvani@yale.edu.
Lancet ; 395(10230): 1163-1166, 2020 04 04.
Article in En | MEDLINE | ID: mdl-32247397

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poliomyelitis / Poliovirus Vaccine, Inactivated / Poliovirus Vaccine, Oral Limits: Humans Language: En Journal: Lancet Year: 2020 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Poliomyelitis / Poliovirus Vaccine, Inactivated / Poliovirus Vaccine, Oral Limits: Humans Language: En Journal: Lancet Year: 2020 Type: Article Affiliation country: United States